课题基金 / 基金详情

ER stress and oligodendrocyte survival after spinal cord injury

ER stress and oligodendrocyte survival after spinal cord injury
脊髓损伤后内质网应激和少突胶质细胞存活
批准号:
8835204
负责人:
MICHAL HETMAN
金额:
$3.72万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-02-01 至 2016-01-31

项目摘要

项目成果

MICHAL HETMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The endoplasmic reticulum (ER) is the intracellular organelle in which secretory and membrane proteins are synthesized and folded by resident chaperone proteins. The ER stress response (ERSR) is an evolutionarily conserved cell defense mechanism that protects against excessive accumulation of malfolded proteins in the ER. These malfolded proteins are translocated to the cytoplasm by the machinery of the ER- associated degredation (ERAD) where they are degraded. The ERSR is initiated after multiple cellular stresses including hypoxia, inflammation, trauma, excitotoxicity, and oxidative damage. The ERSR is initially protective, but if malfolded proteins cannot be cleared, apoptotic cell death initiates. The 3 pathways involved in the ERSR involve PERK, IRE1/XBP-1, and ATF6 signaling. Preliminary data demonstrate upregulation of all 3 ERSR pathways following SCI. Mice null for CHOP, a pro-apoptotic transcription factor that is downstream of PERK and activated during ERSR, showed enhanced functional recovery after SCI and we identified oligodendrocytes as highly vulnerable to ER stress. We hypothesize that enhancing the protective or inhibiting the apoptotic aspects of the ERSR will enhance functional recovery after SCI. In Aim 1, we will potentiate the protective effectors of ERSR and in Aim 2 suppress those that initiate oligodendrocyte apoptosis. We will use a combination of pharmacological agents, constitutive and conditional null mice, as well as cell culture studies using wild type (WT) and available null oligodendrocyte precursor cells (OPCs) and/or siRNAs to address these questions.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
BMAL1/ARNTL plays a critical, non-circadian role in secondary tissue damage after contusive SCI
  • 批准号:
    10058531
  • 项目类别:
  • 资助金额:
    $51.34万
  • 财政年份:
    2020
  • 负责人:
    MICHAL HETMAN
  • 依托单位:
Role of senescent cells in pathogenesis of contusive spinal cord injury
  • 批准号:
    10116681
  • 项目类别:
  • 资助金额:
    $42.92万
  • 财政年份:
    2020
  • 负责人:
    MICHAL HETMAN
  • 依托单位:
BMAL1/ARNTL plays a critical, non-circadian role in secondary tissue damage after contusive SCI
  • 批准号:
    10625506
  • 项目类别:
  • 资助金额:
    $51.51万
  • 财政年份:
    2020
  • 负责人:
    MICHAL HETMAN
  • 依托单位:
The integrated stress response and oligodendrocyte survival after spinal cord injury
  • 批准号:
    10383143
  • 项目类别:
  • 资助金额:
    $53.41万
  • 财政年份:
    2018
  • 负责人:
    MICHAL HETMAN
  • 依托单位:
海外基金